The present study was designed to explore the anti-inflammatory activity of an anti-platelet agent crinumin, by various in vitro and in vivo inflammation models. Firstly, crinumin protein was purified through cation exchange chromatography; then, in vitro activity was estimated by albumin denaturation assay and HRBC membrane stabilization assay. Carrageenan-induced paw oedema and cotton pellet-induced granuloma models were used for in vivo anti-inflammatory activity assessment in rats. In both models, rats were pre-treated for 7 days with crinumin (25–50 µg/ml) and diclofenac sodium (50 µg/ml). Expression of P-selectin (in serum and plasma) through ELISA and NF-κB (in paw and granulomatous tissues) through western blotting was checked. Our results showed that crinumin at both doses (25 or 50 µg/kg of b.w.) significantly (p < 0.05) reduced the paw oedema formation in a dose-dependent manner in the second phase of inflammation and significant (p < 0.05) reduction of wet and dry weight of granuloma was observed indicating the anti-inflammatory potential of crinumin. Crinumin decreased the expression of P-selectin and NF-κB indicating its potential role in decreasing platelet activation and healing inflammation. Histopathological studies additionally proved the efficacy of drug in treating inflammation. The results of the study suggest that the crinumin might have an inhibitory role in atherosclerosis as platelet aggregation and inflammation are the key processes involved in atherosclerotic disorders.
This is a preview of subscription content, log in to check access.
This study was financially supported by Institute Research Project grant from the Indian Institute of Technology (BHU), Varanasi, India (Number: IIT (BHU)/R&D/IRP/2015-16/2903/L). We would like to thank Dr. S.P. Singh, Professor in Department of Biochemistry, Banaras Hindu University for their support in providing research facilities.
Compliance with ethical standards
Conflict of interest
The authors declare that there are no conflicts of interest.
Anbarasi A, Vidhya R (2015) Evaluation of in vitro anti-inflammatory activity of Tephrosia purpurea (Seed). Asian J Pharm Res 5:83–89CrossRefGoogle Scholar
Borthakur A, Bhattacharyya S, Dudeja PK et al (2007) Carrageenan induces interleukin-8 production through distinct Bcl10 pathway in normal human colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 292:G829–G838CrossRefPubMedGoogle Scholar
Bradford MM (1976) A rapid and sensitive for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254CrossRefPubMedGoogle Scholar
Burkill IH (1966) A dictionary of the economic products of the Malay peninsula. Ministry of Agriculture and Cooperative, Kuala LumpurGoogle Scholar
Chaudhari MG, Joshi BB, Mistry KN (2013) In vitro anti-diabetic and anti-inflammatory activity of stem bark of Bauhinia purpurea. Bull Pharm Med Sci 1:139–150Google Scholar
Chen M, Geng JG (2006) P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Arch Immunol Ther Exp 54:75–84CrossRefGoogle Scholar
Ioannis P, Constantinos G, Christos T et al (2014) NF-κB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links. Expert Opin Ther Targets 18:1089–1101CrossRefGoogle Scholar
Karthik K, Bharath RKP, Venu PR et al (2013) Evaluation of anti-inflammatory activity of Canthium parviflorum by in vitro method. Indian J Res Pharm Biotechnol 1:729–730Google Scholar
Kim YH, Kim KH, Han CS et al (2008) Anti-inflammatory activity of Crinum asiaticum Linne var. japonicum extract and its application as a cosmeceutical ingredient. J Cosmet Sci 59:419–430PubMedGoogle Scholar
Leelaprakash G, Dass SM (2011) Invitro anti-inflammatory activity of methanol extract of Enicostemma axillare. Int J Drug Dev Res 3:189–196Google Scholar
Mizushima Y, Kobayashi M (1968) Interaction of anti-inflammatory drugs with serum proteins, especially with some biologically active proteins. J Pharm Pharmacol 20:169–173CrossRefPubMedGoogle Scholar
Müller K, Aichele S, Herkommer M et al (2010) Impact of inflammatory markers on platelet inhibition and cardiovascular outcome including stent thrombosis in patients with symptomatic coronary artery disease. Atherosclerosis 213:256–262CrossRefPubMedGoogle Scholar
Okpo SO, Fatokun F, Adeyemi OO (2001) Analgesic and anti-inflammatory activity of Crinum glaucum aqueous extract. J Ethnopharmacol 78:207–211CrossRefPubMedGoogle Scholar
Olajide OA, Makinde JM, Awe SO (1999) Effects of the aqueous extract of Bridelia ferruginea stem bark on carrageenan-induced oedema and granuloma tissue formation in rats and mice. J Ethnopharmacol 66:113–117CrossRefPubMedGoogle Scholar
Ridker PM (2001) High-sensitivity C-reactive protein potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103:1813–1818CrossRefPubMedGoogle Scholar
Shenoy S, Shwetha K, Prabhu K et al (2010) Evaluation of anti-inflammatory activity of Tephrosia purpurea in rats. Asian Pac J Trop Med 3:193–195CrossRefGoogle Scholar
Singh KA, Kumar R, Rao GRK et al (2010) Crinumin, a chymotrypsin-like but glycosylated serine protease from Crinum asiaticum: purification and physicochemical characterisation. Food Chem 119:1352–1358CrossRefGoogle Scholar
Singh KA, Nayak MK, Jagannadham MV et al (2011) Thrombolytic along with anti-platelet activity of crinumin, a protein constituent of Crinum asiaticum. Blood Cells Mol Dis 47:129–132CrossRefPubMedGoogle Scholar
Steinhubl SR, Badimon JJ, Bhatt DL et al (2007) Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease. Vasc Med 12:113–122CrossRefPubMedGoogle Scholar
Winter CA, Porter CC (1957) Effect of alterations in side chain upon anti-inflammatory and liver glycogen activities of hydrocortisone esters. J Am Pharm Assoc 46:515–519CrossRefGoogle Scholar
Zhanhe J, Alan WM (2000) Amaryllidaceae. Science Press, Beijing, p 264Google Scholar